JP2020083892A5 - - Google Patents

Download PDF

Info

Publication number
JP2020083892A5
JP2020083892A5 JP2019212064A JP2019212064A JP2020083892A5 JP 2020083892 A5 JP2020083892 A5 JP 2020083892A5 JP 2019212064 A JP2019212064 A JP 2019212064A JP 2019212064 A JP2019212064 A JP 2019212064A JP 2020083892 A5 JP2020083892 A5 JP 2020083892A5
Authority
JP
Japan
Prior art keywords
beraprost
monohydrate
solvent
type
following
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019212064A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020083892A (ja
JP6894489B2 (ja
Filing date
Publication date
Priority claimed from US16/199,471 external-priority patent/US10577341B1/en
Application filed filed Critical
Publication of JP2020083892A publication Critical patent/JP2020083892A/ja
Publication of JP2020083892A5 publication Critical patent/JP2020083892A5/ja
Application granted granted Critical
Publication of JP6894489B2 publication Critical patent/JP6894489B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019212064A 2018-11-26 2019-11-25 ベラプロスト−314d・一水和物結晶及びその製造方法 Active JP6894489B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16/199,471 2018-11-26
US16/199,471 US10577341B1 (en) 2018-11-26 2018-11-26 Beraprost-314d monohydrate crystals and methods for preparation thereof

Publications (3)

Publication Number Publication Date
JP2020083892A JP2020083892A (ja) 2020-06-04
JP2020083892A5 true JP2020083892A5 (enExample) 2021-03-25
JP6894489B2 JP6894489B2 (ja) 2021-06-30

Family

ID=68655416

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019212064A Active JP6894489B2 (ja) 2018-11-26 2019-11-25 ベラプロスト−314d・一水和物結晶及びその製造方法

Country Status (6)

Country Link
US (1) US10577341B1 (enExample)
EP (1) EP3656767A1 (enExample)
JP (1) JP6894489B2 (enExample)
KR (1) KR102317032B1 (enExample)
CN (1) CN111217782A (enExample)
TW (1) TWI724651B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11447440B2 (en) * 2020-10-29 2022-09-20 Chirogate International Inc. Treprostinil monohydrate crystals and methods for preparation thereof
CN115611838A (zh) * 2021-07-15 2023-01-17 四川国为制药有限公司 一种前列环素衍生物的晶型

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59134787A (ja) * 1983-01-19 1984-08-02 Toray Ind Inc 5,6,7−トリノル−4,8−インタ−m−フエニレンPGI↓2誘導体の製造法
JP4503942B2 (ja) * 2003-06-11 2010-07-14 大正製薬株式会社 止痒剤
ES2717226T3 (es) * 2011-06-16 2019-06-19 Lung Biotechnology Inc Método de producción de beraprost
EP2968362A4 (en) * 2013-03-15 2016-10-05 Gemmus Pharma Inc BERAPROST ISOMER AS A MEANS FOR THE TREATMENT OF VIRUS INFECTIONS
CN103242274B (zh) * 2013-05-22 2014-11-05 孙威 一种贝前列素钠化合物及其制备方法
WO2015179427A1 (en) * 2014-05-20 2015-11-26 Lung Biotechnology Pbc Methods for producing beraprost and its derivatives
KR101986966B1 (ko) * 2015-08-12 2019-06-07 유나이티드 쎄러퓨틱스 코포레이션 베라프로스트의 제조 방법
HU231080B1 (hu) * 2016-04-05 2020-07-28 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Eljárás optikailag aktív Beraprost előállítására
KR101777632B1 (ko) * 2016-04-11 2017-09-12 연성정밀화학(주) 베라프로스트 나트륨 결정형 및 이의 제조방법

Similar Documents

Publication Publication Date Title
TWI769272B (zh) 奧美卡替莫卡必爾的合成
JP2012500819A5 (enExample)
JP2007308494A (ja) 結晶イマチニブ塩基及びその製造方法
CN110526914B (zh) 一种alk抑制剂的多晶型物及其制备方法
CN1227233C (zh) 纯晶形的5-氯-3-(4-甲磺酰基苯基)-6′-甲基-[2,3′]联吡啶及其合成方法
JP2020083892A5 (enExample)
JP2019505533A5 (enExample)
JP2020535168A5 (enExample)
CN104884427B (zh) 可用于合成苯甲酰胺化合物的化合物
CN114746412A (zh) Kd-025的新晶型及其制备方法
JP7663642B2 (ja) エラミプレチドの合成に有用な結晶性ジペプチド
JP2013505234A (ja) 3−(4−アミノ−1−オキソ−1,3−ジヒドロ−イソインドール−2−イル)−ピペリジン−2,6−ジオンの固形体およびその製造方法
JP2019505532A5 (enExample)
JPWO2020230028A5 (enExample)
CA2377240A1 (en) Process for preparing substituted cyclopentane derivatives and novel crystalline structures thereof
CN111217818A (zh) 芦卡帕尼樟脑磺酸盐的结晶、及制备三环化合物、芦卡帕尼及其樟脑磺酸盐结晶的方法
AU2011284341A1 (en) N-Methylformamide solvate of dasatinib
US6521642B2 (en) 5-chloro-3-(4-methanesulfonylphenyl)-6′-methyl-[2,3′]bipyridinyl in pure crystalline form and process for synthesis
AU2014389984A1 (en) Process of preparing a quinazoline derivative
JP2010502682A5 (enExample)
JPWO2020118113A5 (enExample)
TW201619161A (zh) 培美曲塞二酸之晶型及其製備方法
CN114591236A (zh) 一种茚达特罗的改进制备方法
US20190276399A1 (en) Polymorph of nintedanib
JPWO2020239568A5 (enExample)